| How to manage Pseudomonas aeruginosa infections M Bassetti, A Vena, A Croxatto, E Righi, B Guery Drugs in context 7, 2018 | 822 | 2018 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 718 | 2021 |
| Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission B Guery, J Poissy, L El Mansouf, C Séjourné, N Ettahar, X Lemaire, ... The Lancet 381 (9885), 2265-2272, 2013 | 537 | 2013 |
| The gut-lung axis in health and respiratory diseases: a place for inter-organ and inter-kingdom crosstalks R Enaud, R Prevel, E Ciarlo, F Beaufils, G Wieërs, B Guery, L Delhaes Frontiers in cellular and infection microbiology 10, 9, 2020 | 524 | 2020 |
| Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study C Charlier, É Perrodeau, A Leclercq, B Cazenave, B Pilmis, B Henry, ... The Lancet Infectious Diseases 17 (5), 510-519, 2017 | 482 | 2017 |
| A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit O Leroy, C Santre, C Beuscart, H Georges, B Guery, JM Jacquier, ... Intensive care medicine 21, 24-31, 1995 | 424 | 1995 |
| Role of LecA and LecB Lectins in Pseudomonas aeruginosa-Induced Lung Injury and Effect of Carbohydrate Ligands C Chemani, A Imberty, S de Bentzmann, M Pierre, M Wimmerová, ... Infection and immunity 77 (5), 2065-2075, 2009 | 366 | 2009 |
| Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part II. Treatment BP Guery, MC Arendrup, G Auzinger, É Azoulay, M Borges Sá, ... Intensive care medicine 35, 206-214, 2009 | 343 | 2009 |
| State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans WHO MERS-CoV Research Group PLoS currents 5, 2013 | 316 | 2013 |
| European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults J van Prehn, E Reigadas, EH Vogelzang, E Bouza, A Hristea, B Guery, ... Clinical Microbiology and Infection 27, S1-S21, 2021 | 299 | 2021 |
| Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside? E Faure, J Poissy, A Goffard, C Fournier, E Kipnis, M Titecat, P Bortolotti, ... PloS one 9 (2), e88716, 2014 | 275 | 2014 |
| Diagnostic and prognostic values of admission procalcitonin levels in community–acquired pneumonia in an intensive care unit N Boussekey, O Leroy, H Georges, P Devos, T d’Escrivan, B Guery Infection 33, 257-263, 2005 | 225 | 2005 |
| Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia N Boussekey, O Leroy, S Alfandari, P Devos, H Georges, B Guery Intensive care medicine 32, 469-472, 2006 | 224 | 2006 |
| First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission … A Mailles, K Blanckaert, P Chaud, S Van der Werf, B Lina, V Caro, ... Eurosurveillance 18 (24), 2013 | 216 | 2013 |
| Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial B Guery, F Menichetti, VJ Anttila, N Adomakoh, JM Aguado, ... The Lancet Infectious Diseases 18 (3), 296-307, 2018 | 192 | 2018 |
| A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock N Boussekey, A Chiche, K Faure, P Devos, B Guery, T d’Escrivan, ... Intensive care medicine 34, 1646-1653, 2008 | 172 | 2008 |
| Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis F Lanternier, S Poiree, C Elie, D Garcia-Hermoso, P Bakouboula, ... Journal of Antimicrobial Chemotherapy 70 (11), 3116-3123, 2015 | 168 | 2015 |
| Community-acquired aspiration pneumonia in intensive care units: epidemiological and prognosis data O Leroy, C Vandenbussche, C Coffinier, C Bosquet, H Georges, B Guery, ... American journal of respiratory and critical care medicine 156 (6), 1922-1929, 1997 | 143 | 1997 |
| Antiadhesive Properties of Glycoclusters against Pseudomonas aeruginosa Lung Infection AM Boukerb, A Rousset, N Galanos, JB Méar, M Thepaut, T Grandjean, ... Journal of medicinal chemistry 57 (24), 10275-10289, 2014 | 141 | 2014 |
| Epidemiological features and prognosis of severe community-acquired pneumococcal pneumonia H Georges, O Leroy, C Vandenbussche, B Guery, S Alfandari, L Tronchon, ... Intensive care medicine 25, 198-206, 1999 | 134 | 1999 |
Emmanuel FaureLille 2 University, McGill University, EA7366Verified email at univ-lille2.fr
